RH PetroGas Limited (SGX:T13)

Market Cap	152.97M
Revenue (ttm)	119.96M
Net Income (ttm)	19.09M
Shares Out	835.92M
EPS (ttm)	0.02
PE Ratio	8.01
Forward PE	15.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,352,200
Average Volume	10,686,435
Open	0.1810
Previous Close	0.1870
Day's Range	0.1790 - 0.1860
52-Week Range	0.1200 - 0.2150
Beta	0.66
RSI	51.74
Earnings Date	Aug 8, 2025

About Ligand Pharmaceuticals

RH PetroGas Limited, an investment holding company, engages in the exploration, development, and production of oil and gas resources in Indonesia. It holds 70% working interests in the Kepala Burung production sharing contract (PSC) that covers an area of approximately 1,030 square kilometers; and the Salawati PSC covering a total area of 1,137 square kilometers onshore and offshore located in the Bird’s Head area of West Papua in eastern Indonesia. The company was formerly known as T8ri-M Technologies Singapore Limited and changed its name to ...

• Industry: Printed Circuit Boards
• Founded: 1987
• Employees: 620
• Stock Exchange: Singapore Exchange
• Ticker Symbol: T13

Financial Performance

In 2024, RH PetroGas's revenue was $92.52 million, a decrease of -1.67% compared to the previous year's $94.09 million. Earnings were $14.56 million, an increase of 460.94%.